Author: Ken Dropiewski

Inari Medical to Announce First Quarter 2024 Financial Results

Financial by Comments are Disabled

IRVINE, Calif., April 17, 2024 (GLOBE NEWSWIRE) —  Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its first quarter 2024 financial results on Tuesday, April 30, 2024. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

Continue Reading →

Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates

Financial by 0 comments

WARRINGTON, Pa., April 17, 2024 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today reported financial results for the fourth quarter and fiscal year ended December 31, 2023 and provided key business updates. […]

Continue Reading →

Viz.ai and NICO Corporation Announce Collaboration to Improve Outcomes in Patients with Intracerebral Hemorrhage

Neuro by 0 comments

SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a collaboration with NICO Corporation (NICO), a leader in modern minimally-invasive interventional technologies for neurosurgery, to improve the lives of patients with intracerebral hemorrhages. “We’re excited to collaborate with NICO, leveraging our broadly deployed AI […]

Continue Reading →

SHL Announces Full-Year 2023 Results – Stable Revenue Growth Alongside Groundbreaking Clinical Milestones

Financial by 0 comments

TEL AVIV, Israel & ZURICH & NEW YORK–(BUSINESS WIRE)–SHL Telemedicine Ltd. (NASDAQ: SHLT; SIX Swiss Exchange: SHLTN) (“SHL” or the “Company”), a leading provider and developer of advanced personal telemedicine solutions, announced today its results for the full-year 2023, highlighting fiscally responsible growth across all regions and a strategic focus […]

Continue Reading →

Cardiovascular Centers of America Announces Cardiac Ablation Service Line at Advanced Heart and Vascular in Deltona, Florida

Rhythm by Comments are Disabled

DELTONA, Fla., April 17, 2024 /PRNewswire/ — Cardiovascular Centers of America (CCA) proudly announces the launch of Florida’s the first complete cardiac ablation service line in an Ambulatory Surgery Center (ASC) at Advanced Heart and Vascular Surgery Center (Advanced Cardiovascular)….

Continue Reading →

Milestone® Pharmaceuticals to Present Data on Etripamil at the Preventative Cardiovascular Nursing Symposium

Coronary/Structural Heart by Comments are Disabled

MONTREAL and CHARLOTTE, N.C., April 17, 2024 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will present data on etripamil at the 30th Annual Cardiovascular Nursing Symposium held by the Preventive Cardiovascular Nurses Association on April 18-20th in Orlando, FL. The posters will be available following the embargo at https://MilestonePharma.com.

Continue Reading →

SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR’s SyMRI NEURO Software at SimonMed Facilities

Neuro Radiology by Comments are Disabled

LINKÖPING, Sweden, April 17, 2024 /PRNewswire/ — SimonMed Imaging (“SimonMed”), one of the largest outpatient medical imaging providers and radiology practices in the United States, announces the continuation of its partnership with SyntheticMR for research as well as the upcoming…

Continue Reading →

CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024

Financial by Comments are Disabled

MINNEAPOLIS, April 16, 2024 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative extravascular implantable neuromodulation device for patients with cardiovascular diseases, today announced that it plans to release first quarter 2024 financial and operating results after market close on Tuesday, April 30th, 2024. The Company will host a conference call to review its results at 5:00pm Eastern Time the same day.

Continue Reading →
1 … 268 269 270 271 272 … 1,331